Gilead Sciences Financial Overview
Gilead Sciences's market cap is currently $155.92B. The company's EPS TTM is $2.47; its P/E ratio is 19.47; and it has a dividend yield of 2.52%. Gilead Sciences is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $1.86. See an overview of income statement, balance sheet, and cash flow financials.
